Literature DB >> 12419875

The expression of sialyl Lewis X in canine and feline mammary gland tumors.

Takayuki Nakagawa1, Rina Uyama, Emi Ohashi, Tomoko Takahashi, Sung Hyeol Hong, Manabu Mochizuki, Satoru Matsunaga, Ryouhei Nishimura, Nobuo Sasaki.   

Abstract

The expression of sialyl Lewis X (sLe(x)) in 93 canine and 15 feline mammary gland tumors (MGT) obtained by surgical resection at Veterinary Medical Center, the University of Tokyo was examined by immunohistochemistry. Their clinicopathological features and prognosis were also reviewed. Approximately 60% of MGT tissues showed sLe(x) positive expressions, while all normal mammary gland tissues were negative. However, its expression was not correlated with clinicopathological features and prognosis significantly. This study suggests that sLe(x) may be a tumor-associated antigen in canine and feline MGTs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419875     DOI: 10.1292/jvms.64.949

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  2 in total

1.  LncRNA Expression Profiles in Canine Mammary Tumors Identify lnc34977 as a Promoter of Proliferation, Migration and Invasion of Canine Mammary Tumor Cells.

Authors:  Baochun Lu; Juye Wu; Hebi Chen; Shoujun Li; Kun Jia
Journal:  Vet Sci       Date:  2022-02-15

2.  Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.

Authors:  Salomé S Pinho; Augusto J F Matos; Célia Lopes; Nuno T Marcos; Júlio Carvalheira; Celso A Reis; Fátima Gärtner
Journal:  BMC Cancer       Date:  2007-07-06       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.